Regeneron Pharmaceuticals
E140048
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Regeneron Pharmaceuticals canonical | 6 |
| Regeneron Genetics Center | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1213882 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Regeneron Pharmaceuticals Context triple: [Roy Vagelos, boardMemberOf, Regeneron Pharmaceuticals]
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
C.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
D.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Regeneron Pharmaceuticals Target entity description: Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
C.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
D.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| awarded | multiple FDA approvals for biologic therapies ⓘ |
| collaboratesWith | Sanofi ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| developed |
REGN-COV2
ⓘ
casirivimab and imdevimab antibody cocktail ⓘ |
| developsTreatmentFor |
COVID-19
ⓘ
age-related macular degeneration ⓘ asthma ⓘ atopic dermatitis ⓘ cancer ⓘ diabetic macular edema ⓘ inflammatory diseases ⓘ |
| focusesOn | serious and chronic diseases ⓘ |
| foundedBy |
George D. Yancopoulos
ⓘ
Leonard S. Schleifer ⓘ |
| hasKeyPerson |
George D. Yancopoulos
ⓘ
Leonard S. Schleifer ⓘ |
| hasManufacturingFacilityIn | Rensselaer, New York ⓘ |
| hasRAndDFacilityIn | Tarrytown, New York ⓘ |
| hasSubsidiaryOrUnit |
Regeneron Pharmaceuticals
self-linksurface differs
ⓘ
surface form:
Regeneron Genetics Center
|
| headquartersLocation | Tarrytown, New York ⓘ |
| inception | 1988 ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
VelocImmune technology
ⓘ
rapid antibody discovery platforms ⓘ |
| listedOn |
NASDAQ-100 Index
ⓘ
surface form:
NASDAQ-100 index
S&P 500 Index ⓘ
surface form:
S&P 500 index
|
| notableProduct |
Dupixent
ⓘ
Eylea ⓘ Kevzara ⓘ Libtayo ⓘ |
| researchFocus |
genetics-based drug discovery
ⓘ
monoclonal antibodies ⓘ |
| roleOfGeorge D. Yancopoulos | co-founder and chief scientific officer ⓘ |
| roleOfLeonard S. Schleifer | founder and chief executive officer ⓘ |
| specializesIn |
antibody-based therapies
ⓘ
immunology therapies ⓘ oncology therapies ⓘ ophthalmology therapies ⓘ |
| stockExchange | NASDAQ ⓘ |
| tickerSymbol | REGN ⓘ |
| website | https://www.regeneron.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Regeneron Pharmaceuticals Description of subject: Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
Referenced by (7)
Full triples — surface form annotated when it differs from this entity's canonical label.
Regeneron Pharmaceuticals
→
hasSubsidiaryOrUnit
→
Regeneron Pharmaceuticals
self-linksurface differs
ⓘ
this entity surface form:
Regeneron Genetics Center